<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Data are submitted from long-term follow-ups over 78 patients with Gilbert-Meylengraht's syndrome (71 men and 7 women) </plain></SENT>
<SENT sid="1" pm="."><plain>The above syndrome was identifiable predominantly in those persons aged 15-30 </plain></SENT>
<SENT sid="2" pm="."><plain>A major proportion of the patients (75%) displayed different dyspeptic phenomena and asthenovegetative disturbances, 25% had no complaints </plain></SENT>
<SENT sid="3" pm="."><plain>The principle diagnostic criterion for the syndrome is predominant or solitary elevation of blood serum levels of free (unconjugated, indirect) <z:chebi fb="0" ids="16990">bilirubin</z:chebi> without signs of affection liver, <z:e sem="disease" ids="C0001168" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">obturation</z:e> of the biliary tract, and enhanced <z:mp ids='MP_0010163'>hemolysis</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>This form hyper <z:e sem="disease" ids="C0020433" disease_type="Disease or Syndrome" abbrv="">bilirubinemia</z:e> runs benign course </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> above patients remain able bodied having enough capacity for work </plain></SENT>
<SENT sid="6" pm="."><plain>In exacerbations, it is helpful to prescribe small doses of <z:chebi fb="1" ids="8069">phenobarbital</z:chebi> (0.05-0.15 gr daily), under the influence of which drug the serum level of <z:chebi fb="0" ids="16990">bilirubin</z:chebi> returns to <z:mpath ids='MPATH_458'>normal</z:mpath>, this effect lasting only for a period of the drug administration </plain></SENT>
</text></document>